160 related articles for article (PubMed ID: 38264399)
1. Lactate Dehydrogenase as a Biomarker in Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis.
Mahapatra M; Panda A; Kumar H; Barman D; Talukdar R; Dakshinakabat P
Cureus; 2023 Dec; 15(12):e51008. PubMed ID: 38264399
[TBL] [Abstract][Full Text] [Related]
2. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis.
S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V
Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163
[TBL] [Abstract][Full Text] [Related]
3. Assessment of lactate dehydrogenase enzyme levels in saliva and serum of oral submucous fibrosis and leukoplakia patients.
Panda A; Behura SS; Bhuyan L; Dash KC; Kumar V; Mukherjee S
J Oral Maxillofac Pathol; 2020; 24(1):183. PubMed ID: 32508472
[TBL] [Abstract][Full Text] [Related]
4. Estimation of Salivary and Serum Lactate Dehydrogenase in Oral Submucous Fibrosis.
Mishra S; Kritika C; Bajoria AA; Choudhury P; Sahoo SK; Sangamesh NC
J Int Soc Prev Community Dent; 2018; 8(4):289-295. PubMed ID: 30123759
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of lactate dehydrogenase enzyme activity in saliva and serum of oral submucous fibrosis patients.
Sivaramakrishnan M; Sivapathasundharam B; Jananni M
J Oral Pathol Med; 2015 Jul; 44(6):449-52. PubMed ID: 25224513
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma-A Systematic Review and Meta-Analysis.
Mohapatra D; Panda S; Mohanty N; Panda S; Lewkowicz N; Lapinska B
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511530
[TBL] [Abstract][Full Text] [Related]
7. ABO Blood Groups and Its Association with Oral Cancer, Oral Potentially Malignant Disorders and Oral Submucous Fibrosis- A Systematic Review and Meta-Analysis.
Singh A; Purohit BM
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1703-1712. PubMed ID: 34181324
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Serum Lactate Dehydrogenase Enzyme as a Tumor Marker in Potentially Malignant Disorders: A Systematic Review and Meta-Analysis.
Barbi W; Purohit BM
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2553-2559. PubMed ID: 36037107
[TBL] [Abstract][Full Text] [Related]
10. [Oral squamous cell carcinoma in the background of oral submucous fibrosis - a systematic review].
Kizhakkoottu S; Ramani P
Arkh Patol; 2024; 86(1):57-64. PubMed ID: 38319274
[TBL] [Abstract][Full Text] [Related]
11. Study of the Role of Salivary Lactate Dehydrogenase in Habitual Tobacco Chewers, Oral Submucous Fibrosis and Oral Cancer as a Biomarker.
Mantri T; Thete SG; Male V; Yadav R; Grover I; Adsure GR; Kulkarni D
J Contemp Dent Pract; 2019 Aug; 20(8):970-973. PubMed ID: 31797856
[TBL] [Abstract][Full Text] [Related]
12. Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis.
Kallalli BN; Rawson K; Muzammil ; Singh A; Awati MA; Shivhare P
J Oral Pathol Med; 2016 Oct; 45(9):687-690. PubMed ID: 27132033
[TBL] [Abstract][Full Text] [Related]
13. Salivary LDH in oral cancer and potentially malignant disorders: A systematic review and meta-analysis.
Iglesias-Velázquez Ó; López-Pintor RM; González-Serrano J; Casañas E; Torres J; Hernández G
Oral Dis; 2022 Jan; 28(1):44-56. PubMed ID: 32881152
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review.
Divya B; Vasanthi V; Ramadoss R; Kumar AR; Rajkumar K
J Cancer Res Ther; 2023; 19(3):537-542. PubMed ID: 37470571
[TBL] [Abstract][Full Text] [Related]
15. 8-Isoprostane: A salivary oxidative stress biomarker for oral submucous fibrosis and oral squamous cell carcinoma.
Meera S; Sarangarajan R; Rajkumar K
J Oral Maxillofac Pathol; 2020; 24(2):279-284. PubMed ID: 33456237
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
Choudhari S; Masne S; Bhandare P; Dhumal S
J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
[TBL] [Abstract][Full Text] [Related]
17. Serum C-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: A cross-sectional study.
Gosavi SR; Torkadi AA
J Oral Maxillofac Pathol; 2020; 24(1):46-51. PubMed ID: 32508447
[TBL] [Abstract][Full Text] [Related]
18. Utility of serum and salivary lactate dehydrogenase and uric acid levels as a diagnostic profile in oral squamous cell carcinoma patients.
Anitha G; Kumar KV; Deshpande G; Nagaraj M; Kalyani V
J Oral Maxillofac Pathol; 2022; 26(2):218-227. PubMed ID: 35968187
[TBL] [Abstract][Full Text] [Related]
19. Plasma Fibrinogen Degradation Products as the Nonsurgical Diagnostic Tool for Oral Submucous Fibrosis: A Systematic Review.
Gupta S; Sandhu H; Nadar KT; Ocampo Escobedo RL; Gupta R; Subbappa A; Bhullar HS; Kaur M
J Int Soc Prev Community Dent; 2023; 13(2):89-95. PubMed ID: 37223447
[TBL] [Abstract][Full Text] [Related]
20. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
